Efficacy News and Research

RSS
HGS reports commercialization of late-stage products for systemic lupus and chronic hepatitis C

HGS reports commercialization of late-stage products for systemic lupus and chronic hepatitis C

Market for chronic tophaceous gout medications will be led by drug that resolves tophi in less than a year

Market for chronic tophaceous gout medications will be led by drug that resolves tophi in less than a year

Pfizer/Medivation's AD drug Dimebon may garner peak year sales of $1.5 billion

Pfizer/Medivation's AD drug Dimebon may garner peak year sales of $1.5 billion

Amicus Therapeutics presents corporate outlook for 2010 at Annual J.P. Morgan Healthcare Conference

Amicus Therapeutics presents corporate outlook for 2010 at Annual J.P. Morgan Healthcare Conference

Mango effective against colon and breast cancer

Mango effective against colon and breast cancer

Research shows diet plans can have a major influence on weight loss

Research shows diet plans can have a major influence on weight loss

French maritime pine tree extract effective against hemorrhoids

French maritime pine tree extract effective against hemorrhoids

4SC commences treatment in its resminostat Phase II trial for HL

4SC commences treatment in its resminostat Phase II trial for HL

Sage Bionetworks, Pfizer sign new research partnership to analyze advanced network models of cancer

Sage Bionetworks, Pfizer sign new research partnership to analyze advanced network models of cancer

Second pivotal efficacy study not required for MAP Pharmaceuticals' LEVADEX NDA

Second pivotal efficacy study not required for MAP Pharmaceuticals' LEVADEX NDA

AvidBiotics and Ecolab to develop new technology that reduces food pathogens in meat products

AvidBiotics and Ecolab to develop new technology that reduces food pathogens in meat products

YM BioSciences announces results of cancer antibody-radionuclide conjugate development collaboration

YM BioSciences announces results of cancer antibody-radionuclide conjugate development collaboration

GSK exercises option to obtain exclusive license to develop and commercialize Traficet-EN

GSK exercises option to obtain exclusive license to develop and commercialize Traficet-EN

Pfizer commences SBI-087 Phase 2 clinical trial for RA

Pfizer commences SBI-087 Phase 2 clinical trial for RA

Biocomposites' geneX ds, the resorbable bone graft material with negative surface charge launched

Biocomposites' geneX ds, the resorbable bone graft material with negative surface charge launched

Antares Pharma, Population Council report positive Phase 2 results for novel NES/E2 contraceptive gel

Antares Pharma, Population Council report positive Phase 2 results for novel NES/E2 contraceptive gel

Positive results from KemPharm's KP106 Phase 1 clinical trial for ADHD

Positive results from KemPharm's KP106 Phase 1 clinical trial for ADHD

Interim results from Phase I clinical trials utilizing PLX-PAD for treatment of CLI reported

Interim results from Phase I clinical trials utilizing PLX-PAD for treatment of CLI reported

Positive top-line results from Protox Therapeutics' Phase 2b study of PRX302 announced

Positive top-line results from Protox Therapeutics' Phase 2b study of PRX302 announced

Amarin commences enrollment in its AMR101 Phase 3 clinical trials for cardiovascular disease

Amarin commences enrollment in its AMR101 Phase 3 clinical trials for cardiovascular disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.